Howard Berman

Howard Berman

Directeur/Membre du Conseil chez ATEA PHARMACEUTICALS, INC.

Fortune : 4 M $ au 31/07/2026

52 ans
Health Technology
Consumer Services
Health Services

Profil

Howard H.
Berman
is the founder of Nicoya Health, Inc., founded in 2020.
Dr. Berman was the founder of imaware, Inc., founded in 2018, and served as Director from 2018 to 2024.
Dr. Berman was the founder of Coya Therapeutics, Inc., founded in 2020, and served as Executive Chairman from 2024 to 2026.
Current jobs include Chairman & Chief Executive Officer at ReAlta Life Sciences, Inc. starting in 2026, Independent Director at Atea Pharmaceuticals, Inc. starting in 2025, and Director at Seer, Inc. (California) starting in 2026.
Former job includes Head-Technology Transfer Division at The University of Texas M.D.
Anderson Cancer Center from 2001 to 2003.
Education includes undergraduate degree from the University of Michigan and graduate and doctorate degrees from Weill Cornell Medicine.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
01/05/2026 949 338 ( 4,05 % ) 4 M $ 31/07/2026
18/06/2026 0 ( -.--% ) - $ 31/07/2026

Postes actifs de Howard Berman

SociétésPosteDébut
ATEA PHARMACEUTICALS, INC. Directeur/Membre du Conseil 20/06/2025
SEER, INC. Directeur/Membre du Conseil 28/07/2026
Directeur Général 24/03/2026

Anciens postes connus de Howard Berman

SociétésPosteFin
COYA THERAPEUTICS, INC. Directeur Général 31/10/2024
Fondateur 01/01/2024
Corporate Officer/Principal 01/02/2003
Fondateur -
Voir l'expérience en détail de Howard Berman

Formation de Howard Berman

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

60

Relations au 1er degré

9

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées9

Health Technology

Consumer Services

Consumer Services

Health Technology

Health Technology

Consumer Services

Health Technology

Health Services

Technology Services

  1. Bourse
  2. Insiders
  3. Howard Berman
🔇